Nhà máy Stada
Analgesics & Antipyretics

Partamol 500

Pack sizes:

Box of 10 blisters x 10 film-coated tablets.

Box of 1 bottle x 200 film-coated tablets.


Each film-coated tablet contains paracetamol 500 mg.



48 months from the date of manufacturing.

Store in a well-closed container, in a dry place. Do not store above 30oC.


  • Indications and Dosage & Administration
  • Contraindications
  • Adverse reactions
  • Precautions

  • For treatment of mild to moderate pain and fever, especially in patients in whom salicylates are contraindicated or not tolerated. The drug is most effective in relieving low intensity pain of non-visceral origin.
  • Partamol 500 is administered orally.
  • Adults and children >12 years of age: 500 - 1000 mg every 4 - 6 hours as necessary, but should not exceed 4 g daily.
  • Children 6 - 12 years ofage: 250 - 500 mg every 4 - 6 hours when necessary up to a maximum of4 doses in 24 hours.
  • Paracetamol should not be used for self-medication of pain for longer than 10 days in adults or 5 days in children.
  • Paracetamol should not be used for self-medication of marker fever (greater than 39.5oC), fever persisting longer 3 days, or recurrent fever.

Or as advised by physicians.


  • Patients with anemia or cardiae, pulmonary, renal, or hepatic disease.
  • Patients with alcohol dependence.
  • Patients with known hypersensitivity to paracetamol.
  • Patients with known glucose - 6 - phosphate dehydrogenase deficiency.


  • Skin rash and other allergic reactions occur occasionally. The rash is usuallyerythematosus or urticarial, but sometimes it is more serious and may be accompanied by drug fever and mucosal lesions.


  • Rash.
  • Nausea, vomiting.
  • Blood dyscrasias (neutropenia, pancytopenia, leukopenia), anemia.
  • Nephropathy, nephrotoxicity with chronic abuse.


  • Hypersensitivity reactions.


  • Paracetamol is relatively nontoxic in therapeutic doses. Dermatologic have sometimes reactions including pruritic maculopapular rash and urticaria; other sensitivity reactions including laryngenal edema, angioedema, and anaphylactoid ractions may occur rarely. Thrombocytopenia, leukopenia, and pancytopenia have been associated with the use of p-aminophenol derivatives, especially with prolonged administration of large doses. Neutropenia and thrombocytopenic purpura have been reported with paracetamol use. Rarely, agranulocytosis has been reported in patients receiving paracetamol.
  • Individuals with phenylketonuria (i.e., homozygous deficiency of phenylalanine hydroxylase) who must restrict their intake of phenylalanine should be warned that some paracetamol preparations contain aspartame, which is metabolized in the gastrointestinal tract to phenylalanine following oral administration.
  • Some commercially available formulations of paracetamol contain sulfites that may cause allergic-type reactions, including anaphylaxis and life-threatening or less severe asthmatic episodes, in certain susceptible individuals.
  • Paracetamol should be used with caution in patients with preexisting anemia, since cyanosis may not be apparent despite dangerously high blood concentrations of methemoglobin.
  • Excessive intake of alcohol may increase the risk of paracetamol induced hepatotoxicity; avoid or limit alcohol intake.
  • Caution is recommended when giving to patients with hepatic or renal impairment.
  • The physicians need to warn the patients of the signs of serious skin reactions known as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) or Lyell's syndrome, acute generalized exanthematous pustulosis (AGEP).
  • Pregnancy: Paracetamol is generally considered to be the analgesic of choice in pregnant patients. However, the frequent use of paracetamol in late pregnancy may be associated with an increased risk of persistent wheezing in the infant. Infrequent paracetamol should remain the analgesic of choice in pregnancy.
  • Lactation: No adverse effects have been seen in breast-fed infants whose mothers were receiving paracetamol, the amount of paracetamol distributed into breast milk is too small to be harmful to a breast-fed infant.
  • Effects on ability to drive and use machines: None.


Contact us

FACTORY 1: K63/1 Nguyen Thi Soc St., Xuan Thoi Dong, Hoc Mon, HCMC
Tel: +84 28 3718 2141 - Fax: +84 28 3718 2140

FACTORY 2: 40 Tu Do Avenue, VietNam-Singapore Industrial Park, Binh Duong
Tel: +84 274 376 7470 - Fax: +84 274 376 7469
Email : stada@stada.com.vn
Website: www.stada.com.vn

Visitors Counter